G
GLAB
vs
EXAS
EXAS
Over the past 12 months, GLAB has underperformed EXAS, delivering a return of -90% compared to the EXAS's +102% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
EXAS
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd
CNSX:GLAB
|
0.06
CAD
|
|||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
103.31
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
GLAB, EXAS
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
G
|
Gemina Laboratories Ltd
Revenue
|
|||||||||||
|
Exact Sciences Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
GLAB, EXAS
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
G
|
Gemina Laboratories Ltd
CNSX:GLAB
|
|||||||||
|
Exact Sciences Corp
NASDAQ:EXAS
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd | ||||
|
Exact Sciences Corp | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd | ||||
|
Exact Sciences Corp | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd | ||||
|
Exact Sciences Corp | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd | ||||
|
Exact Sciences Corp | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
G
|
Gemina Laboratories Ltd | ||||
|
Exact Sciences Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
GLAB, EXAS
Performance Gap
GLAB, EXAS
Performance By Year
GLAB, EXAS
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Natera Inc
NASDAQ:NTRA
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| FR |
|
Biomerieux SA
PAR:BIM
|
|
| US |
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| CH |
|
Siegfried Holding AG
SIX:SFZN
|
|
| IT |
|
DiaSorin SpA
MIL:DIA
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
| UK |
|
Abcam PLC
LSE:ABC
|